132 related articles for article (PubMed ID: 21296871)
1. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR
Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871
[TBL] [Abstract][Full Text] [Related]
2. Black raspberries protectively regulate methylation of Wnt pathway genes in precancerous colon tissue.
Wang LS; Kuo CT; Huang TH; Yearsley M; Oshima K; Stoner GD; Yu J; Lechner JF; Huang YW
Cancer Prev Res (Phila); 2013 Dec; 6(12):1317-27. PubMed ID: 24129635
[TBL] [Abstract][Full Text] [Related]
3. Targeting CTCFL/BORIS for the immunotherapy of cancer.
Loukinov D
Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of global DNA hypomethylation in cancer: a meta-analysis.
Li J; Huang Q; Zeng F; Li W; He Z; Chen W; Zhu W; Zhang B
PLoS One; 2014; 9(9):e106290. PubMed ID: 25184628
[TBL] [Abstract][Full Text] [Related]
5. CTCF and BORIS-mediated Autophagy regulation via Alternative splicing of BNIP3L in Breast Cancer.
Pandey A; Kakani P; Shukla S
J Biol Chem; 2024 May; ():107416. PubMed ID: 38810696
[TBL] [Abstract][Full Text] [Related]
6. CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity.
Zambrano-Galván G; Reyes-Romero M; Bologna-Molina R; Almeda-Ojeda OE; Lemus-Rojero O
Case Rep Dent; 2014; 2014():792615. PubMed ID: 25114808
[TBL] [Abstract][Full Text] [Related]
7. DNA hypomethylation in the origin and pathogenesis of human diseases.
Pogribny IP; Beland FA
Cell Mol Life Sci; 2009 Jul; 66(14):2249-61. PubMed ID: 19326048
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
Odunsi K; Matsuzaki J; James SR; Mhawech-Fauceglia P; Tsuji T; Miller A; Zhang W; Akers SN; Griffiths EA; Miliotto A; Beck A; Batt CA; Ritter G; Lele S; Gnjatic S; Karpf AR
Cancer Immunol Res; 2014 Jan; 2(1):37-49. PubMed ID: 24535937
[TBL] [Abstract][Full Text] [Related]
9. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
Debruyne DN; Dries R; Sengupta S; Seruggia D; Gao Y; Sharma B; Huang H; Moreau L; McLane M; Day DS; Marco E; Chen T; Gray NS; Wong KK; Orkin SH; Yuan GC; Young RA; George RE
Nature; 2019 Aug; 572(7771):676-680. PubMed ID: 31391581
[TBL] [Abstract][Full Text] [Related]
10. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
12. Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.
Akhtar MS; Akhter N; Talat A; Alharbi RA; Sindi AAA; Klufah F; Alyahyawi HE; Alruwetei A; Ahmad A; Zamzami MA; Deo S; Husain SA; Badi OA; Khan MJ
Oncotarget; 2023 May; 14():528-541. PubMed ID: 37235839
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid vaccination strategies for ovarian cancer.
Saha C; Bojdo J; Dunne NJ; Duary RK; Buckley N; McCarthy HO
Front Bioeng Biotechnol; 2022; 10():953887. PubMed ID: 36420446
[TBL] [Abstract][Full Text] [Related]
14. CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy.
Salgado-Albarrán M; Späth J; González-Barrios R; Baumbach J; Soto-Reyes E
NPJ Syst Biol Appl; 2022 Feb; 8(1):5. PubMed ID: 35132075
[TBL] [Abstract][Full Text] [Related]
15.
Qazi S; Raza K
J Integr Bioinform; 2021 Nov; 18(4):. PubMed ID: 34788504
[TBL] [Abstract][Full Text] [Related]
16. Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer.
Guo Q; Wang J; Gao Y; Li X; Hao Y; Ning S; Wang P
Front Bioeng Biotechnol; 2020; 8():460. PubMed ID: 32478062
[TBL] [Abstract][Full Text] [Related]
17. Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation.
Nishana M; Ha C; Rodriguez-Hernaez J; Ranjbaran A; Chio E; Nora EP; Badri SB; Kloetgen A; Bruneau BG; Tsirigos A; Skok JA
Genome Biol; 2020 May; 21(1):108. PubMed ID: 32393311
[TBL] [Abstract][Full Text] [Related]
18. Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability.
Zhang W; Klinkebiel D; Barger CJ; Pandey S; Guda C; Miller A; Akers SN; Odunsi K; Karpf AR
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32213861
[TBL] [Abstract][Full Text] [Related]
19. BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.
Janssen SM; Moscona R; Elchebly M; Papadakis AI; Redpath M; Wang H; Rubin E; van Kempen LC; Spatz A
Cell Death Discov; 2020; 6():1. PubMed ID: 32123577
[TBL] [Abstract][Full Text] [Related]
20. The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis.
López-Romero R; Rodríguez-Esquivel M; Romero-Morelos P; García-Avilés JE; Serafín-Castillo A; Huerta-Padilla VM; Guerra-Araiza C; Mantilla-Morales A; Monrroy-García A; Aguilar-Urbano MA; Martínez-Castillo MA; Jiménez-Tenorio JA; Salcedo M
Int J Clin Exp Pathol; 2019; 12(9):3208-3221. PubMed ID: 31934165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
